casgevy

  1. FDA Approves Groundbreaking CRISPR-Based Treatment, Offering Hope to Sickle Cell Patients

    Americas FDA Approves Groundbreaking CRISPR-Based Treatment, Offering Hope to Sickle Cell Patients

    Image Credit: NHLBI In a historic move, the Food and Drug Administration (FDA) has granted approval for Casgevy, a powerful treatment for sickle cell disease, affecting over 100,000 Americans, primarily from the Black community. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, this...
Back
Top